Асцит и его осложнения

1. Hamilton JP, Poordad FF, Venbrux A et al. Portal hypertension. Digestive disease library. The Johns Hopkins University, 2007.
2. Bernardi M, Laffi G, Salvagnini M et al. Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. Liver 1993; 13: 156–62.
3. Runyon BA. Ascites and spontaneous bacterial
peritonitis. In: Feldman M, Friedman LS, Sleisenger MH, editors. Sleisenger & Fordtran's gastrointestinal and liver disease pathophysiology/diagnosis/management. 7th ed. Philadelphia: Saunders; 2002; 1517–42.
4. Arroyo V, Gines P, Gerbes AL et al. Definition and diagnostic criteria of
refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996; 23: 164–76.
5. Anadon MN, Arroyo V. Ascites and spontaneous bacterial peritonitis. In:
Schiff ER, Sorrell MF, Maddrey WC, editors. Schiff 's diseases of the liver. 9th
ed. Philadelphia: Lippincott Williams & Wilkins, 2003; 559–94.
6. Antillon MR, Runyon BA. Postparacentesis plasma expansion prevents
asymptomatic laboratory abnormalities, but does it have any impact on
morbidity or mortality? Gastroenterology 1991; 101: 1455–7.
7. Bass NM. Intravenous albumin for spontaneous bacterial peritonitis in
patients with cirrhosis. N Engl J Med 1999; 341: 443–4.
8. Belghiti J, Durand F. Abdominal wall hernias in the setting of cirrhosis.
Semin Liv Dis 1997; 17: 219–26.
9. Guarner C, Garcia-Tsao G, Navasa M et al. Diagnosis, treatment and
prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000; 32: 142–53.
10. Hu K-Q and Runyon BA. Ascites and its complications. Advanced
Therapy in gastroenterology and liver disease. Bayless Theodore M.,
Diehl Anna Mae, 2005; 113: 656–60.
11. Malinchoc M, Kamath PS, Gordon FD et al. A model to predictpoor
survival in patients undergoing transjugular intrahepatic portosystemic
shunts. Hepatology 2000; 31: 864–71.
12. Rosado B, Kamath PS. Transjugular intrahepatic portosystemic
shunts: an update. Liver Transplantation 2003; 9: 207–17.
13. Rossle M, Ochs A, Gulberg V et al. A comparison of paracentesis and
transjugular intrahepatic portosystemic shunting in patients with
ascites. N Engl J Med 2000; 342: 1701–7.
14. Sort P, Navasa M, Arroyo V et al. Effect of intravenous albumin on
renal impairment and mortality in patients with cirrhosis and spontaneous
bacterial peritonitis. N Engl J Med 1999; 341: 403–9.
15. Strauss RM, Boyer TD. Hepatic hydrothorax. Semin Liv Dis 1997; 17:
227–32.
16. Yu SA, Hu K-Q. Management of ascites.Clin Liv Dis 2001; 5: 541–68.